Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach

Journal of Clinical Pathology

Volumn 51, Issue 9, 1998, Pages 662-666

  Baas, Inge O ^a   Van Rees, Bastiaan P ^a   Musler, Alex ^a   Craanen, Mike E ^b   Tytgat, Guido N J ^b   Van Den Berg, Frank M ^a   Offerhaus, G Johan A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Department of Gastroenterology ^*

Author keywords

Carcinoma; Epstein Barr virus; Gastric stump; H pylori; P53; Stomach

Indexed keywords

ADULT; AGED; ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; VIRUS CARCINOGENESIS;

EID: 0031696083     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.9.662     Document Type: Article

References (34)

1. Howson CP, Hiyama T, Wynders EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
2. La Vecchia C, Luccini F, Negri E, et al. Trends of cancer mortality in Europe, 1955-1989. I. Digestive sites. Eur J Cancer 1992;28:132-5.
3. Saini A, Waxman J. Chemotherapy for gastric cancer. Gut 1992;33:1153-4.
4. Murayama K, Okabayashi K, Kinoshita T. The progress in gastric cancer surgery in Japan and its limits of radicality. World J 1987;11:418-26.
5. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: a pathobiological classification. Cancer 1977;39:2475-85.
6. Correa P. Precursors of gastric and esophageal cancers. Cancer 1982;50:2554-65.
7. Goldstone AR, Quirke P, Dixon MF. Helicobacter pylori infection and gastric cancer. J Pathol 1996;179:129-37.
8. Solcia E, Fiocca R, Luinetti O, et al. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20(suppl 1):S8-22.
9. Caygill CPJ, Hill MJ, Kirkham JS, et al. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986;i:929-31.
10. Offerhaus GJA, Tersmette AC, Huibregtse K, et al. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut 1988;29:1588-90.
11. Tersmette AC, Goodman SN, Offerhaus GJA, et al. Multivariate analysis of the risk of gastric cancer after peptic ulcer surgery in an Amsterdam cohort of postgastrectomy patients. Am J Epidemiol 1991;134:14-21.
12. Offerhaus GJA, Stadt J van de, Huibregtse K, et al. Endoscopie screening for malignancy in the gastric remnant. The clinical significance of dysplasia in gastric mucosa. J Clin Pathol 1984;37:748-54.
13. Offerhaus GJA, Stadt J van de, Huibregtse K, et al. The mucosa of the gastric remnant harboring malignancy. Histological findings in the biopsies of 504 asymptomatic patients 15-46 years after partial gastrectomy with the emphasis on non-malignant lesions. Cancer 1989;64:698-703.
14. Offerhaus GJA, Stadt J van de, Samson G, et al. Cell proliferation kinetics in the gastric remnant. Eur J Cancer Res Clin Oncol 1985;21:73-9.
15. Offerhaus GJA. Gastric stump cancer: lessons from old specimens. Lancet 1994;343:66-7.
16. Uchino S, Noguchi M, Ochiai A, et al. p53 Mutation in gastric cancer: a genetic model lor carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 1993;54:759-64.
17. Wright PA, Williams GT. Molecular biology and gastric carcinoma. Gut 1993;34:145-7.
18. Correa P. A human model of gastric carcmogenesis. Cancer Ka 1988;48:3554-60.
19. Baker SJ, Preisinger AC, Jessup JM, et al. p53 Gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50:7717-22.
20. Craanen ME, Blok P, Dekker W, et al. Chronology of p53 protein accumulation in gastric carcinogenesis. Gut 1995; 36:848-52.
21. Baas IO, Mulder JWR, Offerhaus GJA, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
22. Kern SE, Kinzler KW, Bruskin A, et al. Identification of p53 as a sequence-specific DNA-binding protein. Science 1991; 252:1708-11.
23. El-Deiry WS, Tokino T, Velculescu VE, et al. Waf1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
24. EI-Deiry WS, Takahashi T, Waldman T, et al. Topological control of p21 WAF/CIP1 expression in normal and neoplastic tissue. Cancer Res 1995;55:2910-19.
25. WAF/CIP1 in colorectal carcinoma. Br J Cancer 1996;74:165-71.
26. Harn HJ, Chang JY, Wang MW, et al. Epstein-Barr virus-associated gastric adenucarcinoma in Taiwan. Hum Pathol 1995;26:267-71.
27. Tokunaga M, Uemura Y, Tokudome T, et al. Epstein-Barr virus related gastric cancer in Japan: a molecular pathoepidemiological study. Acta Pathol Japon 1993;43:574-81.
28. Imai S, Koizumi S, Sugiura M, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994;91:9131-5.
29. Tokunaga M, Land CE, Uemura Y, et al. Epstein-Barr Virus in gastric carcinoma. Am J Pathol 1993;143:1250-4.
30. Szekely L, Selivanova G, Magnusson KP, et al. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Acad Sci USA 1993;90:5455-9.
31. Tersmette AC, Offerhaus GJA, Giardiello FM, et al. Longterm prognosis of partial gastrectomy for benign conditions: survival and smoking related death of 2633 Amsterdam postgastrectomy patients followed since surgery between 1931 and 1960. Gastroenterology 1991;101: 148-53.
32. Orterhaus GJA, Tersmette AC, Giardiello FM, et al. Evaluation of endoscopy for early detection of gastric stump cancer. Lancet 1992;340:33-5.
33. Baas IO, Berg FM van den, Mulder JWR, et al. Potential false positive results with antigen enhancement for immuno-histochemistry of the p53 gene product in colorectal neoplasms. J Pathol 1996;178:264-7.
34. Offerhaus GJA, Rieu PNM, Jansen JBMJ, et al. Prospective-comparative study of the influence of bile reflux on human mucosal histology and Campylobacter pylori infection. Gut 1989;30:1552-7.